Yüklüyor......
Immunotherapy for metastatic prostate cancer
Chemotherapy with docetaxel is the standard treatment for men with metastatic prostate cancer, and results in statistically significant improvements in survival, as well as in quality of life. However, the response rate to single-agent docetaxel is approximately 40% to 45%, emphasizing a need for al...
Kaydedildi:
| Yayımlandı: | Urol Oncol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2007
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4886229/ https://ncbi.nlm.nih.gov/pubmed/18593624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2007.03.029 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|